LUNAI: DECODING LIFE. DISCOVERING CURES.

Harnessing phenomics and AI to turn disease signals into new therapies.

We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.

Where Biology Meets Breakthrough

Medicine doesn't advance through static data alone. It advances when we understand life as it unfolds. The signals, shifts, and hidden pathways that define disease and response.
At Lunai, we capture those patterns at scale with AI and prove them in models that respond like human biology.
The result?
Discoveries that don't just predict outcomes, but hold up in reality.
This is how we move from possibility to proof.

Living Systems.
Real Answers.

Traditional discovery splits between two paths: prediction without proof, or proof without scale.
Lunai brings them together. Our AI identifies patterns across millions of data points, and our living models confirm which of those patterns matter for patients.
We see how treatments act, how side effects appear, and how mechanisms unfold, bridging discovery and clinical relevance in one workflow.

Discovery connected to validation, built for real-world medicine

Augusta - AI/ML Engine

Integrates genomic, proteomic, and phenotypic data into one view of disease. Finds hidden signatures that conventional methods miss, uncovering therapeutic targets and biomarkers with true clinical relevance.

Phenograph - Translational System

Transforms raw insights into therapeutic strategies. Prioritizes targets by druggability, patient stratification, and clinical feasibility, creating clear pathways from discovery to patient benefit.

In Vivo Modeling - High Throughput + Machine Vision

Combines living zebrafish models with AI analysis to uncover mechanisms and treatment effects traditional methods overlook. Tracks behavior, morphology, and physiology in real time, exposing efficacy and safety that static models can’t reveal.

Medicine Has Many Frontiers.
Lunai Reaches Them All.

Oncology
Predictive biomarkers identify responders with precision, improving patient stratification and strengthening confidence in immunotherapy and targeted therapy development. Resistance mechanisms are surfaced earlier, enabling therapies to reach the right patients faster.
Neurology
Complex disorders like epilepsy demand more than molecular data. Lunai integrates behavioral, electrical, and physiological signals to reveal mechanisms and treatment effects that conventional models cannot resolve.
Biosecurity
The same platform capabilities extend to preparedness. Real-time neurotoxicity assessment delivers actionable insight for rapid countermeasures and stronger global resilience.

Positioned for Value Creation in Precision Medicine

Drug discovery has lived in silos, algorithms guessing, experiments chasing. Lunai closes that divide. Prediction and proof now live in one system, designed for the future of medicine.

Our platform is:

Integrated

Lunai brings them together. Our AI identifies patterns across millions of data points, and our living models confirm which of those patterns matter for patients.

Validated

Already trusted by leading pharmaceutical partners across therapeutic domains.

Versatile

Extending from oncology and neurology into biosecurity.

Proven

Processing millions of phenotypic datapoints annually, compressing timelines and lowering attrition.

Led with Experience

Guided by leadership with deep track records in biotechnology and AI.
Drug discovery is entering a new era, one defined not by guesswork, but by evidence drawn directly from biology. Lunai is built for that shift.
Biomarker discovery and validation.
Drug development powered
by AI-biology integration.
Target identification and validation.
Neurology-focused
compound development.
Strategic R&D collaborations.

Work With Us

Lunai collaborates across the ecosystem, from pharma partners accelerating programs, to investors shaping the future of medicine, to researchers advancing discovery.
If you’re building the next frontier of precision medicine, we’d like to hear from you.